Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2020-2026

Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
1.4 Market Analysis by Type
1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Over-the-counter (OTC) Testing Kits
1.4.3 Prescription-based Testing Kits
1.5 Market by Application
1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Bacterial Infections
1.5.3 Fungal Infection
1.5.4 Virus Infection
1.5.5 Cardiovascular Infection
1.5.6 Gastrointestinal Infection
1.5.7 Sexually Transmitted Disease (STD) Infection
1.5.8 Central Nervous System Infection
1.5.9 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Infectious Disease Point of Care Diagnostics Market Perspective (2015-2026)
2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Infectious Disease Point of Care Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Infectious Disease Point of Care Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Market Size
3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
3.2.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2019
3.3 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
3.4 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
3.5 Date of Enter into Infectious Disease Point of Care Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2021-2026)
5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
6.2 Infectious Disease Point of Care Diagnostics Key Players in North America (2019-2020)
6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
7.2 Infectious Disease Point of Care Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
8.2 Infectious Disease Point of Care Diagnostics Key Players in China (2019-2020)
8.3 China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
8.4 China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
9.2 Infectious Disease Point of Care Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
10.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
11.2 Infectious Disease Point of Care Diagnostics Key Players in India (2019-2020)
11.3 India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
11.4 India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2015-2020)
12.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
13.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Siemens
13.2.1 Siemens Company Details
13.2.2 Siemens Business Overview and Its Total Revenue
13.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
13.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.2.5 Siemens Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview and Its Total Revenue
13.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
13.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Accriva
13.4.1 Accriva Company Details
13.4.2 Accriva Business Overview and Its Total Revenue
13.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
13.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.4.5 Accriva Recent Development
13.5 Terumo
13.5.1 Terumo Company Details
13.5.2 Terumo Business Overview and Its Total Revenue
13.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
13.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.5.5 Terumo Recent Development
13.6 BioMerieux
13.6.1 BioMerieux Company Details
13.6.2 BioMerieux Business Overview and Its Total Revenue
13.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
13.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.6.5 BioMerieux Recent Development
13.7 Diasorin
13.7.1 Diasorin Company Details
13.7.2 Diasorin Business Overview and Its Total Revenue
13.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
13.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.7.5 Diasorin Recent Development
13.8 Roche
13.8.1 Roche Company Details
13.8.2 Roche Business Overview and Its Total Revenue
13.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
13.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.8.5 Roche Recent Development
13.9 Danaher Corporation
13.9.1 Danaher Corporation Company Details
13.9.2 Danaher Corporation Business Overview and Its Total Revenue
13.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
13.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.9.5 Danaher Corporation Recent Development
13.10 BD
13.10.1 BD Company Details
13.10.2 BD Business Overview and Its Total Revenue
13.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
13.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
13.10.5 BD Recent Development
13.11 Bio-Rad Laboratories
10.11.1 Bio-Rad Laboratories Company Details
10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
10.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
10.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.11.5 Bio-Rad Laboratories Recent Development
13.12 Cavidi
10.12.1 Cavidi Company Details
10.12.2 Cavidi Business Overview and Its Total Revenue
10.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
10.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.12.5 Cavidi Recent Development
13.13 Cepheid
10.13.1 Cepheid Company Details
10.13.2 Cepheid Business Overview and Its Total Revenue
10.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
10.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.13.5 Cepheid Recent Development
13.14 Diaxonhit
10.14.1 Diaxonhit Company Details
10.14.2 Diaxonhit Business Overview and Its Total Revenue
10.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
10.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.14.5 Diaxonhit Recent Development
13.15 Eiken Chemical
10.15.1 Eiken Chemical Company Details
10.15.2 Eiken Chemical Business Overview and Its Total Revenue
10.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
10.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.15.5 Eiken Chemical Recent Development
13.16 EMD Millipore
10.16.1 EMD Millipore Company Details
10.16.2 EMD Millipore Business Overview and Its Total Revenue
10.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
10.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.16.5 EMD Millipore Recent Development
13.17 Epitope Diagnostic
10.17.1 Epitope Diagnostic Company Details
10.17.2 Epitope Diagnostic Business Overview and Its Total Revenue
10.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
10.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.17.5 Epitope Diagnostic Recent Development
13.18 Euroimmun
10.18.1 Euroimmun Company Details
10.18.2 Euroimmun Business Overview and Its Total Revenue
10.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
10.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.18.5 Euroimmun Recent Development
13.19 Gold Standard Diagnostics
10.19.1 Gold Standard Diagnostics Company Details
10.19.2 Gold Standard Diagnostics Business Overview and Its Total Revenue
10.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
10.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.19.5 Gold Standard Diagnostics Recent Development
13.20 Hologic
10.20.1 Hologic Company Details
10.20.2 Hologic Business Overview and Its Total Revenue
10.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
10.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.20.5 Hologic Recent Development
13.21 Immunetics
10.21.1 Immunetics Company Details
10.21.2 Immunetics Business Overview and Its Total Revenue
10.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
10.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.21.5 Immunetics Recent Development
13.22 InBios International
10.22.1 InBios International Company Details
10.22.2 InBios International Business Overview and Its Total Revenue
10.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
10.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020)
10.22.5 InBios International Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Infectious Disease Point of Care Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
Table 3. Ranking of Global Top Infectious Disease Point of Care Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Over-the-counter (OTC) Testing Kits
Table 6. Key Players of Prescription-based Testing Kits
Table 7. Global Infectious Disease Point of Care Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Infectious Disease Point of Care Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Infectious Disease Point of Care Diagnostics Market Growth Strategy
Table 17. Main Points Interviewed from Key Infectious Disease Point of Care Diagnostics Players
Table 18. Global Infectious Disease Point of Care Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Infectious Disease Point of Care Diagnostics Market Share by Players (2015-2020)
Table 20. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019)
Table 21. Global Infectious Disease Point of Care Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
Table 24. Date of Enter into Infectious Disease Point of Care Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Infectious Disease Point of Care Diagnostics Market Size Share by Type (2015-2020)
Table 28. Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Type (2021-2026)
Table 29. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2015-2020)
Table 30. Global Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Infectious Disease Point of Care Diagnostics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 34. North America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 36. North America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 38. Europe Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 40. Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 42. Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 44. China Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 46. China Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 47. China Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 48. China Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 49. China Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 50. Japan Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 52. Japan Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 54. Japan Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 58. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 60. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 62. India Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 64. India Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 65. India Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 66. India Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 67. India Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Infectious Disease Point of Care Diagnostics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Infectious Disease Point of Care Diagnostics Market Share (2019-2020)
Table 70. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Type (2015-2020)
Table 72. Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Infectious Disease Point of Care Diagnostics Market Share by Application (2015-2020)
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Product
Table 77. Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 78. Abbott Recent Development
Table 79. Siemens Company Details
Table 80. Siemens Business Overview
Table 81. Siemens Product
Table 82. Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 83. Siemens Recent Development
Table 84. GE Healthcare Company Details
Table 85. GE Healthcare Business Overview
Table 86. GE Healthcare Product
Table 87. GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 88. GE Healthcare Recent Development
Table 89. Accriva Company Details
Table 90. Accriva Business Overview
Table 91. Accriva Product
Table 92. Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 93. Accriva Recent Development
Table 94. Terumo Company Details
Table 95. Terumo Business Overview
Table 96. Terumo Product
Table 97. Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 98. Terumo Recent Development
Table 99. BioMerieux Company Details
Table 100. BioMerieux Business Overview
Table 101. BioMerieux Product
Table 102. BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 103. BioMerieux Recent Development
Table 104. Diasorin Company Details
Table 105. Diasorin Business Overview
Table 106. Diasorin Product
Table 107. Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 108. Diasorin Recent Development
Table 109. Roche Business Overview
Table 110. Roche Product
Table 111. Roche Company Details
Table 112. Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 113. Roche Recent Development
Table 114. Danaher Corporation Company Details
Table 115. Danaher Corporation Business Overview
Table 116. Danaher Corporation Product
Table 117. Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 118. Danaher Corporation Recent Development
Table 119. BD Company Details
Table 120. BD Business Overview
Table 121. BD Product
Table 122. BD Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 123. BD Recent Development
Table 124. Bio-Rad Laboratories Company Details
Table 125. Bio-Rad Laboratories Business Overview
Table 126. Bio-Rad Laboratories Product
Table 127. Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 128. Bio-Rad Laboratories Recent Development
Table 129. Cavidi Company Details
Table 130. Cavidi Business Overview
Table 131. Cavidi Product
Table 132. Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 133. Cavidi Recent Development
Table 134. Cepheid Company Details
Table 135. Cepheid Business Overview
Table 136. Cepheid Product
Table 137. Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 138. Cepheid Recent Development
Table 139. Diaxonhit Company Details
Table 140. Diaxonhit Business Overview
Table 141. Diaxonhit Product
Table 142. Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 143. Diaxonhit Recent Development
Table 144. Eiken Chemical Company Details
Table 145. Eiken Chemical Business Overview
Table 146. Eiken Chemical Product
Table 147. Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 148. Eiken Chemical Recent Development
Table 149. EMD Millipore Company Details
Table 150. EMD Millipore Business Overview
Table 151. EMD Millipore Product
Table 152. EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 153. EMD Millipore Recent Development
Table 154. Epitope Diagnostic Company Details
Table 155. Epitope Diagnostic Business Overview
Table 156. Epitope Diagnostic Product
Table 157. Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 158. Epitope Diagnostic Recent Development
Table 159. Euroimmun Company Details
Table 160. Euroimmun Business Overview
Table 161. Euroimmun Product
Table 162. Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 163. Euroimmun Recent Development
Table 164. Gold Standard Diagnostics Company Details
Table 165. Gold Standard Diagnostics Business Overview
Table 166. Gold Standard Diagnostics Product
Table 167. Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 168. Gold Standard Diagnostics Recent Development
Table 169. Hologic Company Details
Table 170. Hologic Business Overview
Table 171. Hologic Product
Table 172. Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 173. Hologic Recent Development
Table 174. Immunetics Company Details
Table 175. Immunetics Business Overview
Table 176. Immunetics Product
Table 177. Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 178. Immunetics Recent Development
Table 179. InBios International Company Details
Table 180. InBios International Business Overview
Table 181. InBios International Product
Table 182. InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2015-2020) (Million US$)
Table 183. InBios International Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Point of Care Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Over-the-counter (OTC) Testing Kits Features
Figure 3. Prescription-based Testing Kits Features
Figure 4. Global Infectious Disease Point of Care Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Bacterial Infections Case Studies
Figure 6. Fungal Infection Case Studies
Figure 7. Virus Infection Case Studies
Figure 8. Cardiovascular Infection Case Studies
Figure 9. Gastrointestinal Infection Case Studies
Figure 10. Sexually Transmitted Disease (STD) Infection Case Studies
Figure 11. Central Nervous System Infection Case Studies
Figure 12. Other Case Studies
Figure 13. Infectious Disease Point of Care Diagnostics Report Years Considered
Figure 14. Global Infectious Disease Point of Care Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Point of Care Diagnostics Market Share by Regions: 2020 VS 2026
Figure 16. Global Infectious Disease Point of Care Diagnostics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Infectious Disease Point of Care Diagnostics Market Share by Players in 2019
Figure 19. Global Top Infectious Disease Point of Care Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Point of Care Diagnostics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2019
Figure 21. North America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Infectious Disease Point of Care Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abbott Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 30. Siemens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Siemens Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 32. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GE Healthcare Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 34. Accriva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Accriva Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 36. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Terumo Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 38. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. BioMerieux Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 40. Diasorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Diasorin Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 42. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Roche Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 44. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Danaher Corporation Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 46. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. BD Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 48. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 50. Cavidi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cavidi Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 52. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cepheid Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 54. Diaxonhit Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Diaxonhit Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 56. Eiken Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Eiken Chemical Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 58. EMD Millipore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. EMD Millipore Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 60. Epitope Diagnostic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Point of Care Diagnostics Business (2015-2020)
Figure 62. Euroimmun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Euroimmun Revenue Growth Rate in Infectious Disease Point of Care Diagn

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs